Clinical Trial Update: Subcutaneously Administered Interleukin-2 Therapy in HIV-Infected Patients [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating subcutaneously administered interleukin-2 therapy in HIV-infected patients. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infection | Phase 2 | Status: COMPLETED